Bactobio
London
About Bactobio
Bactobio uses breakthrough technologies in synthetic biology, next-generation sequencing and machine learning to harvest novel microbes and screen them for medical and industrial applications. It aims to help solve the antibiotic resistance crisis by discovering novel antibiotic classes targeting some of the most urgent bacterial pathogens - before moving on to broader applications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $12.6M
- Funding stage: Seed
- Last round: Convertible Note (Dec 2022)
- Website: bacto.bio
- Phone: [email protected]
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/bactobio-82108 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.